Press Releases from DelveInsight (457 total)
Bipolar Disorder Pipeline: Innovative Advancements with 20+ Leading Companies De …
The Bipolar Disorder (Manic Depression) market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Lyndra Therapeutics, Alzamend…
Coronary Artery Disease Pipeline: Trailblazing Advancements with Over 30 Leading …
The Coronary Artery Disease market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as GHelixmith, Amgen, Angionetics, Xylocor…
Diabetic Foot Ulcers Pipeline: Leading Innovation with 20+ Groundbreaking Therap …
The Diabetic Foot Ulcers market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Cell2Cure ApS, Lakewood-Amedex, and…
Immune Thrombocytopenic Purpura Pipeline: 30+ Pioneers Driving Innovation in Tra …
The Immune Thrombocytopenic Purpura market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Sanofi, Takeda, Rigel Pharmaceuticals,…
Scleroderma Pipeline: Pioneering Progress with 40+ Leading Companies Developing …
The Scleroderma market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Certa Therapeutics, Argenx, Cumberland Pharmaceuticals, Sanofi,…
Etanercept Biosimilars Pipeline: 15+ Innovators Pioneering Breakthrough Therapie …
The Etanercept market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Lupin, Intas Biopharmaceuticals, and Merck. These…
Knee Osteoarthritis Pipeline: Over 50 Innovators Pioneering Breakthrough Therapi …
The Knee Osteoarthritis market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as AOrient Europharma Co., Ltd., Paradigm…
Influenza Pipeline: Advancing Innovation with 120+ Trailblazers Developing Trans …
The Influenza market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as AlloVir, Cocrystal Pharma, Poolbeg Pharma, and…
Hypertension Pipeline Progresses: 100+ Therapies Pushing Innovation - DelveInsig …
Fueled by relentless research, the Hypertension pipeline is witnessing transformative developments, with key players accelerating breakthroughs in treatment.
DelveInsight's "Hypertension Pipeline Insight, 2025" comprehensively analyzes the…
Natural Killer NK Cell Lymphoma Pipeline Expands with 100+ Companies Leading Inn …
With groundbreaking advancements from industry leaders, the Natural Killer NK Cell Lymphoma pipeline continues to grow, redefining treatment strategies and improving patient outcomes.
DelveInsight's "Natural Killer…
DelveInsight's Ovarian Cancer Pipeline Report Highlights 180+ Industry Trailblaz …
The Ovarian Cancer treatment landscape is evolving, driven by cutting-edge research and innovative therapies from top pharmaceutical players, offering renewed hope for patients.
DelveInsight's "Ovarian Cancer…
High-Grade Glioma Pipeline: DelveInsight Reports 150+ Innovators Driving Breakth …
DelveInsight's "High-Grade Glioma Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the High-Grade Glioma market. The report covers disease insights,…
Chronic Myeloid Leukemia Pipeline: Driving Innovation with 25+ Pioneering Compan …
The chronic myelocytic leukemia market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Aprea Therapeutics, Treadwell Therapeutics,…
Chronic Heart Failure Pipeline: Advancing Innovation with 25+ Pioneers Shaping t …
The chronic heart failure market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Tasly Pharmaceuticals, Berlin Cures,…
Beta-Thalassemia Pipeline: Advancing Innovation with 22+ Trailblazers Developing …
The beta-thalassemia market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Disc Medicine, Novartis, Merck, and Bristol…
Attention Deficit Hyperactivity Disorder Pipeline: Advancing Innovation with 20+ …
The attention deficit hyperactivity disorder market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as 3Z Pharmaceuticals, Shire,…
Amyotrophic Lateral Sclerosis Pipeline: Advancing the Future with 50+ Innovators …
The amyotrophic lateral sclerosis market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Denali Therapeutics, AbbVie, Calico…
Thrombocytopenia Pipeline: Transforming Treatment with 25+ Pioneers Driving Brea …
The thrombocytopenia market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Novartis Pharmaceuticals, Pfizer, HUTCHMED, Genosco, and UCB.…
Pancreatic Ductal Adenocarcinoma Pipeline: Shaping the Future with 80+ Innovator …
The pancreatic ductal adenocarcinoma market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Eucure Biopharma, Panbela Therapeutics, and…
Chronic Urticaria Pipeline: Unleashing Hope with 20+ Innovators like UCB Biophar …
The chronic urticaria or hives market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Novartis, Synermore Biologics,…
Ischemia Reperfusion Injury Pipeline: Pioneering the Future with 10+ Innovators …
The ischemia-reperfusion injury market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Calluna Pharma and CalciMedica. These…
Ischemic Stroke Pipeline: Pioneering the Future with 50+ Innovators Driving Brea …
The Ischemic Stroke market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as NuvOx Pharma, Healios, Acticor Biotech, and…
Malignant Mesothelioma Clinical Pipeline | 20+ Companies, Including Epizyme, Ys …
The Malignant Mesothelioma market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Epizyme, Ys Therapeutics, Novartis, Bayer,…
Hyperkalemia Clinical Pipeline | Eli Lilly, Novo Nordisk, Sanofi, Ardelyx, and O …
The hyperkalemia market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Eli Lilly, Novo Nordisk, Sanofi, and Ardelyx.…
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generatio …
The Motor Neuron Disease market is evolving rapidly, driven by cutting-edge research and innovative treatment approaches. Leading pharmaceutical companies like GeneCradle Therapeutics, Verge Genomics, QurAlis…
Tau Inhibitors Clinical Pipeline | 20+ Companies Advancing the Future of Treatme …
The Tau Inhibitors market is rapidly advancing, driven by breakthrough research and innovative therapies from leaders like TauRx Therapeutics, Prothena, and UCB Biopharma. These pioneers…
Complement Inhibitors Clinical Pipeline | Over 50 Companies Driving the Future o …
The Complement Inhibitors market is advancing rapidly, driven by groundbreaking research and innovative therapies from leaders like NovelMed Therapeutics, Arrowhead Pharmaceuticals, and BioCryst Pharmaceuticals. These…
Renal Cancer Clinical Pipeline | 75+ Companies, Including Genentech, AstraZeneca …
The Renal Cancer market is evolving with cutting-edge research and new therapeutic advancements.
DelveInsight's 'Renal Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline…
Advanced Kidney Cancer Clinical Pipeline | 50+ Companies Transforming the Future …
The Advanced Kidney Cancer market is rapidly evolving with cutting-edge research and breakthrough therapies, driven by leading companies like Janux Therapeutics, Infinity Pharmaceuticals, Merck Sharp…
Squamous Cell Carcinoma Clinical Pipeline | 75+ Companies Advancing the Future o …
The Squamous Cell Carcinoma market is rapidly evolving with cutting-edge research and breakthrough therapies driven by leading companies like AstraZeneca, VCN Biosciences, Moderna Therapeutics, Exelixis,…
Complicated Urinary Tract Infections Clinical Pipeline, 12+ Companies Driving th …
The market for Complicated Urinary Tract Infections is rapidly evolving, driven by groundbreaking research and innovative therapeutic advancements.
DelveInsight's 'Complicated Urinary Tract Infections Pipeline Insight 2024'…
Ulcerative Colitis Clinical Pipeline | 70+ Companies Pioneering the Next Breakth …
The ulcerative colitis market is undergoing a transformative shift, driven by cutting-edge research and innovative therapies.
DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive…
Psoriatic Arthritis Clinical Pipeline | 20+ Companies Driving the Next Wave of I …
The Psoriatic Arthritis market is advancing rapidly, driven by groundbreaking research and innovative therapies.
DelveInsight's 'Psoriatic Arthritis Pipeline Insight 2024' report provides comprehensive global coverage of…
AL Amyloidosis Clinical Pipeline | 10+ Companies Advancing the Next Breakthrough …
The AL Amyloidosis market is evolving with cutting-edge research and new therapeutic advancements.
DelveInsight's 'AL Amyloidosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline…
Follicular Lymphoma Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Follicular Lymphoma Pipeline constitutes 50+ key companies continuously working towards developing 55+ Follicular Lymphoma treatment therapies, analyzes DelveInsight.
Follicular Lymphoma Overview:
Follicular lymphoma (FL) is an indolent…
CAR-T Cell Therapy Competitive Landscape 2024 (Updated)
DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T -…
Anterior Uveitis Treatment Market Size Report 2032 | DelveInsight
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as…
Antiphospholipid Syndrome Treatment Market Size 2032 | Genentech Inc, Bayer, Lum …
Antiphospholipid Syndrome market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand…
Atopic Dermatitis Market to grow significantly by 2032 | Sanofi, Regeneron Pharm …
(Delhi, India) To strategically aid companies developing drugs for Atopic Dermatitis, DelveInsight launched the report "Atopic Dermatitis Market" This comprehensive report delves into epidemiology-based market…
Behçet's Disease Pipeline Outlook Report 2024 | Latest Drug Approvals, FDA, Cli …
DelveInsight's, "Behçet's Disease Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Behçet's Disease pipeline landscape. It covers Behçet's…
C-MET Non-Small Cell Lung Cancer Pipeline Outlook Report 2024 | Latest Drugs App …
DelveInsight's, "C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the C-MET…
Dry Age-Related Macular Degeneration Pipeline Outlook, FDA Approvals, Emerging D …
DelveInsight's, "Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration…
Allergic Rhinitis APAC Market Poised for Phenomenal Expansion Across APAC Region …
"DelveInsight's "Allergic Rhinitis- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Allergic Rhinitis, historical and forecasted…
Severe Asthma Market Forecast 2034: FDA, EMA, PDMA Approvals, Clinical Trials, E …
DelveInsight's report titled "Severe Asthma Market Insights, Epidemiology, and Market Forecast - 2034" comprehensively analyzes Severe Asthma. The report provides a comprehensive analysis of historical…
Triple Negative Breast Cancer Pipeline, Clinical Trials, FDA Approvals, Research …
DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Triple Negative Breast Cancer Companies and 80+ pipeline drugs in Triple…
Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials Developments, and Comp …
DelveInsight's, "Multiple Myeloma Pipeline Insights" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It…
Postherpetic Neuralgia Market Size in 7MM is expected to witness a major change …
"The Postherpetic Neuralgia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple-…
Acute Pain Pipeline, Clinical and Non-Clinical Stages Products, and FDA Approval …
DelveInsight's, "Acute Pain Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Acute Pain pipeline landscape. It covers…
Cystic Fibrosis Pipeline, Clinical Trials Assessment, NDA Approvals, Emerging Dr …
DelveInsight's, "Cystic Fibrosis Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers…
Metastatic Pancreatic Cancer Pipeline and Clinical Trials Pipeline Analysis 2023 …
DelveInsight's, "Metastatic Pancreatic Cancer Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It…
